SecSonar.com

Immuron Limited (IMRN)

Immuron Limited at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Immuron Limited (IMRN) is a Biotechnology company based in AU with a market capitalization of $8.5M. Revenue grew 48.6% year-over-year and free cash flow was negative at -$4.3M. This page tracks IMRN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

AU · 7 employees · IPO Jun 9, 2017

Valuation

Valuation & price

$1.00 · as of May 26, 2026 · -57.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.27$1.48$0.70Jul 25Dec 25Jul 26Jul 7, 25$1.73Jul 9, 25$1.75Jul 11, 25$1.74Jul 15, 25$1.87Jul 17, 25$1.89Jul 21, 25$1.68Jul 23, 25$1.75Jul 25, 25$1.72Jul 29, 25$1.66Jul 31, 25$1.62Aug 4, 25$1.68Aug 6, 25$1.64Aug 11, 25$1.66Aug 13, 25$1.73Aug 15, 25$1.81Aug 19, 25$1.76Aug 21, 25$1.83Aug 25, 25$1.81Aug 27, 25$1.78Aug 29, 25$1.83Sep 3, 25$1.86Sep 5, 25$1.86Sep 9, 25$1.80Sep 11, 25$1.91Sep 16, 25$1.83Sep 18, 25$1.81Sep 22, 25$1.94Sep 24, 25$1.92Sep 26, 25$1.94Sep 30, 25$1.90Oct 2, 25$2.06Oct 6, 25$2.24Oct 8, 25$2.27Oct 10, 25$2.07Oct 14, 25$2.05Oct 16, 25$2.20Oct 21, 25$2.27Oct 23, 25$2.16Oct 27, 25$2.20Oct 29, 25$2.10Oct 31, 25$1.90Nov 4, 25$1.73Nov 6, 25$1.66Nov 10, 25$1.61Nov 12, 25$1.61Nov 14, 25$1.58Nov 18, 25$1.56Nov 20, 25$1.62Nov 25, 25$1.74Nov 28, 25$1.71Dec 2, 25$1.74Dec 4, 25$1.56Dec 8, 25$1.47Dec 10, 25$1.12Dec 12, 25$1.02Dec 16, 25$0.96Dec 18, 25$0.94Dec 22, 25$0.94Dec 24, 25$0.88Dec 29, 25$0.84Jan 2, 26$0.80Jan 6, 26$0.83Jan 8, 26$0.82Jan 12, 26$0.98Jan 14, 26$1.03Jan 16, 26$1.06Jan 21, 26$0.98Jan 23, 26$0.98Jan 27, 26$0.95Jan 29, 26$0.91Feb 2, 26$0.90Feb 4, 26$0.81Feb 9, 26$0.75Feb 11, 26$0.73Feb 13, 26$0.74Feb 18, 26$0.72Feb 20, 26$0.72Feb 24, 26$0.72Feb 26, 26$0.84Mar 2, 26$0.76Mar 4, 26$0.75Mar 6, 26$0.88Mar 10, 26$0.87Mar 12, 26$0.81Mar 17, 26$0.75Mar 19, 26$0.71Mar 23, 26$0.70Mar 25, 26$0.77Mar 27, 26$0.80Mar 31, 26$0.77Apr 2, 26$0.80Apr 7, 26$0.79Apr 9, 26$0.80Apr 13, 26$0.79Apr 15, 26$0.82Apr 17, 26$0.96Apr 22, 26$0.88Apr 24, 26$0.89Apr 28, 26$0.82Apr 30, 26$0.82May 4, 26$0.81May 6, 26$0.82May 8, 26$0.80May 12, 26$0.80May 14, 26$1.11May 18, 26$1.00May 20, 26$0.99May 22, 26$1.00May 28, 26$1.21Jun 1, 26$1.41Jun 3, 26$1.37Jun 5, 26$1.25Jun 9, 26$1.19Jun 11, 26$1.24Jun 15, 26$1.16Jun 17, 26$1.07Jun 22, 26$1.15Jun 24, 26$1.08Jun 26, 26$1.10Jul 2, 26$1.10
$0.7052-week range$2.35
Loading valuation history…

Fundamentals

Key fundamentals

$8.5M

Market cap

48.6%

Revenue growth (YoY)

65.4%

Gross margin

-$4.3M

Free cash flow (USD)

-$5.7M

Net debt

Net cash position

1.4%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.0MFY 2017$1.4MFY 2018$1.8MFY 2019$2.4MFY 2020$2.5MFY 2021$145.8KFY 2022$765.2KFY 2023$1.8MFY 2024$4.9MFY 2025$7.3M
$1M$7.3M

Free cash flow by year

2016 → 2025

FY 2016$-3.8MFY 2017$-7.0MFY 2018$-3.5MFY 2019$-1.3MFY 2020$-3.2MFY 2021$-3.1MFY 2022$-3.1MFY 2023$-2.5MFY 2024$-5.9MFY 2025$-6.1M
-$3.8M-$6.1M

Gross margin by year

2021 → 2025

FY 2021-456.2%FY 202268.4%FY 202396.4%FY 202468.1%FY 202565.4%
-456.2%65.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed Apr 17, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingNotification of Cessation of SecuritiesJun 29, 2026Filing
  • 6-K filingUnmarketable Parcel Facility UpdateJun 23, 2026Filing
  • 6-K filingNotification of Cessation of SecuritiesJun 22, 2026Filing
  • 6-K filingResponse to ASX Price QueryMay 28, 2026Filing
  • 6-K filingEmerging Growth Conference PresentationMay 8, 2026Filing
  • 6-K filingEmerging Growth Conference PresentationApr 30, 2026Filing
  • Quarterly reportQuarterly Report FiledApr 17, 2026Filing
  • 6-K filingSmall Holding Share Sale FacilityApr 13, 2026Filing

Questions

Frequently asked questions

What is Immuron Limited's market cap?

Immuron Limited (IMRN) has a market capitalization of $8.5M.

What is IMRN's P/E ratio?

A meaningful P/E ratio is not available for IMRN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying IMRN stock?

SEC Form 4 filings show no open-market insider buys at Immuron Limited in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

SYBX

Synlogic, Inc.

$7.8M

JUNS

Jupiter Neurosciences, Inc.

$9.5M

TCRT

Alaunos Therapeutics, Inc.

$7.4M

CRIS

Curis, Inc.

$7M

CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

$6.7M

ICU

SeaStar Medical Holding Corporation

$10.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.